Qiagen Nv Dividend yield




   EUR/share 
 Price  41.27
 Dividend  0.00
 Earnings  1.76
 Cash-flow  1.75
 Book value  10.07
 Equity  9.94

Qiagen Nv is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Qiagen Nv is a company from Germany, and his stocks are publicly traded.

Qiagen Nv paid a total dividend of 0 million EUR last year, for a market value of 9,410 millions (Market Cap 9,097 millions). Dividend per share of Qiagen Nv is 0.00 EUR, and his stock market price 41.27 EUR.

According to the chart below where dividend yield is displayed, Qiagen Nv, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Germany, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Qiagen Nv might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Qiagen Nv dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Germany.

Dividend yield of Qiagen Nv

Qiagen Nv Dividend Payout

About the ability of Qiagen Nv to maintain his current dividend of EUR 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Qiagen Nv payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Qiagen Nv, compared againt world market average, Germany companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Qiagen Nv payout

Qiagen Nv Dividend History

Year Yield  EUR  Paypout  Shares* 
Present0.00%0.000.00%228
20200.00%0.000.00%228
20190.00%0.000.00%227
20180.00%0.000.00%227
20170.00%0.000.00%228
20160.00%0.000.00%226
20150.00%0.000.00%226

*In millions

Qiagen Nv Stock performance

Finally, last moth Qiagen Nv showed a return of 0.70% compared to a worldwide 4.25% average, and a 3.06% of Health Care firms. Over the last year, the company obtained a 12.70% versus a worldwide performance of a 53.42%. More detailed information can be seen in the following graph for Germany and Pharmaceuticals and Biotechnology firms.

Qiagen Nv stock and market return